Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Blood Research
>
2020
>
55
>
S1
Volume:
55
Issue:
S1
1. Treatments for children and adolescents with AML
Page:S5—S13
2. New agents in acute myeloid leukemia (AML)
Page:S14—S18
3. Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation
Page:S19—S26
4. Optimal therapy for adolescents and young adults with acute lymphoblastic leukemia-current perspectives
Page:S27—S31
5. Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia
Page:S32—S36
6. Classification of acute myeloid leukemia
Page:S1—S4
7. Frontline therapy for newly diagnosed patients with multiple myeloma
Page:S37—S42
8. Treatment of relapsed and refractory multiple myeloma
Page:S43—S53
9. AL amyloidosis: advances in diagnosis and management
Page:S54—S57
10. Recent advances in the management of primary central nervous system lymphoma
Page:S58—S62
11. Extranodal NK/T cell lymphoma
Page:S63—S71
12. Recent advances in chronic lymphocytic leukemia therapy
Page:S72—S82